The IL-20 Cytokine Family in Rheumatoid Arthritis and Spondyloarthritis

Tue Wenzel Kragstrup(Aarhus University), Bent Deleuran(Aarhus University), Thomas T. Andersen(Albany Medical Center Hospital), Ladislav Šenolt(Charles University), Malene Hvid(Aarhus University), Peter C. Taylor(Nuffield Orthopaedic Centre), Jens Gerwien(University of Messina), Pallavur V. Sivakumar, Line Dam Heftdal(University of Copenhagen)

Frontiers in Immunology

September 25, 2018

10.3389/fimmu.2018.02226

Cited by 71

Related Papers

Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic

|Science|2004|800

EULAR definition of difficult-to-treat rheumatoid arthritis

|Annals of the Rheumatic Diseases|2020|538

Association of Family History of Autoimmune Diseases and Autism Spectrum Disorders

|PEDIATRICS|2009|409

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

|The Lancet|2021|324

Chitosan/siRNA Nanoparticle–mediated TNF-α Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model

|Molecular Therapy|2008|298